Conceptus, Inc.Mountain View, CA United States
Company Description
Despite what the name seems to connote, Conceptus works to prevent conception, not help it along. The company develops, makes, and markets women's health care products, namely a minimally invasive permanent birth control procedure called Essure. Soft, flexible micro-insert devices are placed in the fallopian tubes without incisions, allowing tissue to grow over them as a barrier for the egg. Essure does not contain hormones and is designed to become effective after three months. Conceptus markets Essure primarily to gynecologists in the US through a direct sales force and internationally through distributors in Europe, Australia, Central and South America, and the Middle East, among other locations.
| 331 E. Evelyn | Phone: 650-628-4700 | |
| Mountain View, CA 94041 | Fax: 650-610-8368 | |
| United States |
Conceptus, Inc. Rankings
| Russell 2000 (June 2011) |
Executives
| 24 executives listed for Conceptus, Inc.'s Mountain View, CA location. | ||
| Chairman | Kathryn Tunstall | |
|---|---|---|
| President, CEO, and Director | Mark Sieczkarek | |
| EVP Operations, CFO, and Treasurer | GregoryLichtwardt | |
Financials
| Company Type | Public - NASDAQ: CPTS Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 299 |
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Conceptus, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
